Abstract & Details
Description
Award ID: 2015013
The broader impact of this Small Business Technology Transfer Phase I project will be a new instrument to study agents causing human disease and damage to the environment. This technology enables better studies of viruses and large chemicals for public health and life sciences research. This new capability will also enable the study of interactions between proteins in the body, a critical aspect of many diseases. In addition, this new instrument can be used for continuous monitoring of drug and vaccine production to ensure high quality. The proposed STTR Phase I project focuses on the development of a new type of mass spectrometry, known as distance-of-flight mass spectrometry; and a new detector capable of detecting ultra-high molecular weight ions. Conventional mass spectrometry detectors depend on high-velocity collisions of the target ions on a small area of the detector, releasing an electron from the collision surface for subsequent amplification. Unfortunately, this strategy of ion detection fails for large ions. The proposed project will incorporate a new type of mass spectrometer that spatially distributes ions along an array of ion charge detectors according to their mass-to-charge ratio. The approach has no upper mass limit to the ions that can be separated, and thus is an optimum method to determine the mass of large ions. Further, by detecting the ion charge directly as opposed to the impact event, the new approach is able to detect massive ions. Having separate detectors arrayed by mass also enables collection of the ions after analysis. When the new detector is developed and incorporated into the mass spectrometer, the unique capabilities will be demonstrated by analyzing micelles under development as drug delivery vehicles. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
NSF Program Director: Erik Pierstorff
The broader impact of this Small Business Technology Transfer Phase I project will be a new instrument to study agents causing human disease and damage to the environment. This technology enables better studies of viruses and large chemicals for public health and life sciences research. This new capability will also enable the study of interactions between proteins in the body, a critical aspect of many diseases. In addition, this new instrument can be used for continuous monitoring of drug and vaccine production to ensure high quality. The proposed STTR Phase I project focuses on the development of a new type of mass spectrometry, known as distance-of-flight mass spectrometry; and a new detector capable of detecting ultra-high molecular weight ions. Conventional mass spectrometry detectors depend on high-velocity collisions of the target ions on a small area of the detector, releasing an electron from the collision surface for subsequent amplification. Unfortunately, this strategy of ion detection fails for large ions. The proposed project will incorporate a new type of mass spectrometer that spatially distributes ions along an array of ion charge detectors according to their mass-to-charge ratio. The approach has no upper mass limit to the ions that can be separated, and thus is an optimum method to determine the mass of large ions. Further, by detecting the ion charge directly as opposed to the impact event, the new approach is able to detect massive ions. Having separate detectors arrayed by mass also enables collection of the ions after analysis. When the new detector is developed and incorporated into the mass spectrometer, the unique capabilities will be demonstrated by analyzing micelles under development as drug delivery vehicles. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
NSF Program Director: Erik Pierstorff
| Status | Closed |
|---|---|
| Effective start/end date | 06/01/20 → 04/30/22 |
Lead and Sub-Awardee Organization(s)
Funding
- STTR Phase I: $225,000.00
Active Fiscal Year
- FY2022
Start Fiscal Year
- FY2020
TIP Programs
- STTR Phase I
Small Business
- Yes
Key Technology Areas
- Biotechnology
- (confidence score: 99%)
Technology Foci
- Biotechnology (Broad)
- (confidence score: 100%)
Congressional District at Award
- District n. 03 of New Mexico
Current Congressional District
- District n. 03 of New Mexico
United States
- New Mexico
Core Based Statistical Area (CBSA)
- Santa Fe, NM
County
- County: Santa Fe, NM
EPSCoR Jurisdiction
- Yes
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint. Learn more about Elsevier's Fingerprint Engine here: https://beta.elsevier.com/products/elsevier-fingerprint-engine